Why urothelial cancer for checkpoint inhibitor therapeutics - 102038

Spotlight
Video

Why urothelial cancer for checkpoint inhibitor therapeutics

Loading........
Description: Robert Dreicer, MD of the University of Virginia answers the question why urothelial cancer for checkpoint inhibitor therapeutics
Shared By : AnnualMeeting2016
Posted on : 06/21/16
Added : 2 years ago
Category : Urology